Subcutaneous hydration in palliative care v2.4 Final

to palliative care patients in all care environments. 1.2 It has been produced to ensure consistent practice, use and equitable access to subcutaneous fluids across the West Midlands region. 2 Guideline Background 2.1 Subcutaneous hydration (previously known as hypodermoclysis) is a technique used for

  Care, Palliative, Hydration, Subcutaneous, Palliative care, All care, Subcutaneous hydration in palliative care

These Guidelines were originally developed for Mercy ...

GUIDELINES FOR WOUND MANAGEMENT IN PALLIATIVE CARE Wayne Naylor - BSc(Hons), PG Cert (Palliative Care), Dip Nursing, Oncology cert. (ENB 237), RCompN Wayne Naylor is a New Zealand registered nurse who began his career in forensic

  Guidelines, Care, Wound

Use of dexamethasone formulations in palliative care: a ...

8–16mg 6.6–13.2mg (2–4mL) 7.6–15.2mg (2–4mL) Spinal cord compression 16mg 13.2mg (4mL) 15.2mg (4mL) a. generally given once daily in the morning (see text) b. prednisolone 15−40mg each morning is an alternative c. also see PCF Quick Prescribing Guide: Management of nausea and vomiting. Table 2 ...

Clinical protocol for the use of syringe drivers in ...

syringe drivers in palliative care patients (adults) ... • Once the alarm has fi nished, releasing the button starts the syringe driver • Do not use the pump if the motor does not stop or the alarm does not sound • Check that the indicator lamp is fl ashing (the lamp will begin to …

  Patients, Drivers, Pumps, Care, Adults, Palliative, Syringes, Syringe drivers in palliative care patients

Anticipatory drugs and syringe driver chart V2

Syringe driver combinations containing octreotide, methadone, ketorolac, ketamine or furosemide Pr escribe appr o v ed name o f drug en t er ed in C A P I T A L S Diluen ts R esour c es f or in f orma tion F or pa tien ts with r enal f ailur e Please if uncertain about drug compatibilities seek advice Specialist palliative care/ hospice ...

  Drug, Drivers, Care, Palliative, Syringes, Palliative care, Compatibilities, Syringe driver, Drug compatibilities

Guidelines for Ketamine Use - © palliativedrugs.com

St Joseph's Mercy Hospice Auckland NZ Guidelines for Ketamine Use Ketamine is a dissociative anaesthetic agent which has analgesic properties in sub-

  Guidelines, Guidelines for ketamine use, Ketamine

090714 opioid conversions - © palliativedrugs.com

Choice of opioid This is obviously dependent on the individual patient, but as a general rule, use: • Morphine as first line opioid via oral and subcutaneous routes

  Opioid, Conversion, 090714 opioid conversions, 090714

Isle of Wight Syringe Driver Compatibility Guidelines

This is intended to guide primary and secondary care clinicians throughout the Isle of Wight in deciding which medicines can be combined for use with subcutaneous syringe drivers. Roles and responsibilities Adherence to St Marys Medicines Policy, and to GMC, NMC and GPhC professional standards, are assumed: users of

  Wight

SUMMARY OF PRODUCT CHARACTERISTICS - © …

SUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the medicinal product OxyNorm 10 mg/ml, solution for injection or infusion 2. Qualitative and Quantitative Composition Oxycodone hydrochloride 10 mg/ml

  Product, Summary, Characteristics, Summary of product characteristics

NPSA Appendix 1 Injectable Medicines Risk Assessment Tool

Prepare all additions to TPN in a pharmacy aseptic unit or use closed system products that can be prepared in near ... e.g. double dilution or complex rate of administration such as microgram/kg/hour A complex method - e.g. non-standard diluent, ... Instructions for

  Administration, Instructions

[P] Dexamethasone - Palliative Care

Medicines & Infusion Protocols (Adults)/ 1d Palliative Care Dexamethasone - Palliative Care (Adults) Issued by Pharmacy and Hospital Palliative Care Team Issued Date July 2016 Classification 014-001-01-067 ... oxycodone, hyoscine hydrobromide, hyoscine butylbromide2, 3, 4

  Care, Palliative, Palliative care, Hyoscine, Dexamethasone, Hydrobromide, Hyoscine hydrobromide, Dexamethasone palliative care, Palliative care dexamethasone palliative care

Hyoscine Hydrobromide Scopoderm PIL - Scottish Palliative …

in palliative care are quite often used this way. There is experience and research to support the use of hyoscine hydrobromide in this way. The person who prescribed your medicine will have considered carefully the benefits for you. Information on this is not included in the information leaflet supplied with the medicine.

  Care, Palliative, Palliative care, Hyoscine, Hydrobromide, Hyoscine hydrobromide

Management of Respiratory Secretions in the Terminal …

Hyoscine Butylbromide (Buscopan®) 20mg stat (7) or Hyoscine Hydrobromide (Hyoscine) 0.4mg stat (7,8) GENERAL APPROACH Patient care: Nurse the person on their side, reposition to other side every 3-4 hours. Elevate the head of the bed slightly, retaining a position of comfort Provide frequent mouth care (every 1-2 hours).

  Management, Care, Respiratory, Terminal, Secretions, Hyoscine, Hydrobromide, Hyoscine hydrobromide, Management of respiratory secretions in the terminal

End of Life and Palliative Care Medication Prescribing

Palliative Care Medicines List for NSW Community Pharmacy for use in the last days of life. Core Medicine Indication/(s) for use in the last days of life Clonazepam 1 mg/mL Injection Anxiety Terminal restlessness Haloperidol 5 mg/mL Injection Nausea Hyoscine butylbromide 20 mg/mL Injection Noisy breathing Metoclopramide 10 mg/2mL Injection

  Care, Palliative, Palliative care, Hyoscine

To mix or not to mix – compatibilities of parenteral drug …

Palliative care There are a number of drugs that are commonly delivered via syringe driver to patients having palliative care in the community (see box). Combinations of two, three or more of these drugs occasionally need to be co-administered via syringe driver. Specialist references dealing with their mutual compatibilities need to be ...

  Care, Palliative, Palliative care

World Health Organization Model List of Essential Medicines

2. MEDICINES FOR PAIN AND PALLIATIVE CARE 2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) acetylsalicylic acid Suppository: 50 mg to 150 mg. Tablet: 100 mg to 500 mg. ibuprofen a Oral liquid: 200 mg/5 mL. Tablet: 200 mg; 400 mg; 600 mg. a Not in children less than 3 months. paracetamol* Oral liquid: 120 mg/5 mL; 125 mg/5 mL.

  Lists, Care, Essential, Medicine, List of essential medicines, Palliative, Palliative care

WHO EML 22nd List (2021)

2. MEDICINES FOR PAIN AND PALLIATIVE CARE 2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) acetylsalicylic acid Suppository: 50 mg to 150 mg. Tablet: 100 mg to 500 mg. ibuprofen a Oral liquid: 200 mg/5 mL. Tablet: 200 mg; 400 mg; 600 mg. a Not in children less than 3 months. paracetamol* Oral liquid: 120 mg/5 mL; 125 mg/5 mL.

  Care, Palliative, Palliative care